Evidence map›Paper›PMID 18777992›Full record

Trial reportWMJ : official publication of the State Medical Society of Wisconsin2008

A comparison of the nicotine lozenge and nicotine gum: an effectiveness randomized controlled trial.

Quinn R Pack, Douglas E Jorenby, Michael C Fiore, Thomas Jackson, Patricia Weston, Megan E Piper, Timothy B Baker

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in WMJ : official publication of the State Medical Society of Wisconsin, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Interventions for preventing weight gain after smoking cessation.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Pooled it
  3. Trial
  4. Single-Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations.Clinical pharmacology in drug development · 2018
    Trial
  5. Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers.Clinical pharmacology in drug development · 2018
    Trial
  6. Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
.International journal of clinical pharmacology and therapeutics · 2018
    Trial
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Quinn R PackDepartment of Medicine, University of Wisconsin, Madison, WI, USA.
Douglas E Jorenby
Michael C Fiore
Thomas Jackson
Patricia Weston
Megan E Piper
Timothy B Baker
University of Wisconsin–Madison · US

Funding

RELAPSE: LINKING SCIENCE AND PRACTICEP50CA084724 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FIORE, MICHAEL C · 1999 to 2003
$8.9M
Tobacco Dependence: Treatment and OutcomesP50DA019706 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON-POWELL, GLORIA · 2004 to 2008
$8.6M
NCI NIH HHS P50 CA084724NCI NIH HHS P50CA084724NIDA NIH HHS P50 DA019706
6 · The paper itself

Abstract

contextBoth the nicotine gum and nicotine lozenge have been shown to increase smoking cessation rates, but no published trials have directly compared the two. Higher dose nicotine gum has been recommended as a treatment that may reduce cessation-related weight gain. DESIGN/OUTCOME: In a diverse urban setting, 408 participants were randomized to receive either the lozenge or the gum for 8 weeks of treatment. Seven-day point prevalence of smoking abstinence was biochemically confirmed by exhaled carbon monoxide levels of less than 10 ppm measured at 8 weeks with follow-up at 6 and 12 months.

resultsAt 8 weeks, the lozenge quit rate was 15.1% and the gum quit rate was 11.3%, with an odds ratio of 1.39, 95% confidence interval (0.78-2.49) P=0.26. These rates compare favorably to a historical spontaneous quit rate of 5%. Quit rate comparisons were similarly non-significant at 6 and 12 months. At 8 weeks, successful quitters in the lozenge group gained 3.0+/-6.3 lbs compared to the gum group, which gained 8.4+/-9.2 lbs with t=-2.4, P=0.02, but this finding was not sustained at 6 and 12 months.

conclusionsThe gum and lozenge appear equally effective for smoking cessation; however, for patients concerned about preventing cessation related to immediate weight gain, the lozenge may be the better agent.

Indexed as

Smoking PreventionAdultChewing GumFemaleHumansLogistic ModelsMaleNicotineNicotinic AgonistsSmoking CessationTreatment OutcomeChewing GumNicotineNicotinic Agonists

Identifiers

PMID18777992
PMCPMC3174063
OpenAlexW2273713021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.